Cancer, Cancer Treatments, Biotechnology, Treatment, Science.
model. These findings confirmed that the increase in dLN-tumor repertoire was due to clonal spreading, i.e., the expansion of diverse polyclonal clones, and not clonal skewing, i.e., the expansion of oligoclonal clones. The team further found that increase of the polyclonal fraction of OL